Myla Lai-Goldman

Myla Lai-Goldman

Directeur/Membre du Conseil chez WEST PHARMACEUTICAL SERVICES, INC.

Fortune : 6 M $ au 31/05/2026

68 ans
Health Technology
Health Services
Commercial Services

Profil

Myla P.
Lai-Goldman
was the founder of CancerGuide Diagnostics, Inc., founded in 2009, where the title held was Chief Executive & Scientific Officer from 2009 to 2010.
Dr. Lai-Goldman is the founder of GeneCentric Therapeutics, Inc., founded in 2011, holding the title of Executive Chairman since 2019.
Dr. Lai-Goldman is the founder of Personalized Science LLC, founded in 2009, serving as Managing Partner since 2009.
Current jobs include Independent Director at West Pharmaceutical Services, Inc. since 2015, Director at Council for Entrepreneurial Development, Director at NovoPath LLC since 2022, Independent Director at Quanterix Corp.
starting 2025, Director at Qvella Corp., Director at Mercy BioAnalytics, Inc. since 2023, and Venture Partner at Hatteras Venture Partners since 2011.
Former jobs include Independent Director at Sequenom, Inc. from 2013 to 2016, Medical Director at Center for Molecular Biology & Pathology from 1991 to 2004, Independent Director at Akoya Biosciences, Inc. from 2021 to 2025, Executive VP, Chief Medical & Scientific Officer at Laboratory Corporation of America Holdings from 1991 to 2008, Executive VP, Chief Medical & Scientific Officer at Roche Biomedical Laboratories, Inc., Principal at National Genetics Institute, Inc., and Principal at Viro-Med Laboratories, Inc. Education includes a doctorate from The Trustees of Columbia University in The City of New York conferred in 1983 and an undergraduate degree from the University of Pennsylvania conferred in 1979.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/05/2026 19 424 ( 0,03 % ) 6 M $ 31/05/2026
15/04/2026 6 968 ( 0,01 % ) 21 322 $ 31/05/2026

Postes actifs de Myla Lai-Goldman

SociétésPosteDébut
WEST PHARMACEUTICAL SERVICES, INC. Directeur/Membre du Conseil 17/02/2014
QUANTERIX CORPORATION Directeur/Membre du Conseil 08/07/2025
Private Equity Investor 01/08/2011
Directeur/Membre du Conseil 01/01/2022
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 24/04/2023
Directeur/Membre du Conseil -
Fondateur 01/01/2011
Fondateur 01/01/2009

Anciens postes connus de Myla Lai-Goldman

SociétésPosteFin
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Myla Lai-Goldman

Formation de Myla Lai-Goldman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

89

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Services

Health Technology

Health Services

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Process Industries

Finance

Commercial Services

Commercial Services

Center for Molecular Biology & Pathology

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Bourse
  2. Insiders
  3. Myla Lai-Goldman
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇